- FDA approves olaparib for germline BRCA-mutated metastatic breast cancer
FDA, Jan 12, 2018
- The risk of unjustified BRCA testing after the "Angelina Jolie effect": how can we save (laboratory) medicine from the Internet?
Lippi Giuseppe et al. Clinical chemistry and laboratory medicine 2017 Jul
lunes, 26 de febrero de 2018
From Genomics & Health Impact Scan Database
This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.